While most investors are focused on for-profit psychedelics organizations, non-profits have been responsible for much of the progress that has occurred in the psychedelics ecosystem over the past several decades.
Research, clinical trials, public education, policy reform, and many other initiatives have been created, supported, and funded by psychedelic focused non-profits. The results from many of these initiatives have significantly impacted the development of the broader psychedelic medicine ecosystem.
The below is a treemap chart that Psychedelic Invest created, in partnership with Neuly, of active psychedelics non-profits.
Data from Neuly
Want to update your organization’s information? Click here to let us know what’s changed.